ASHM, May 2024 Contraception Essentials: Navigating a Consultation is a video resource designed to support clinicians in their contraceptive consultations. The video guides clinicians to utilise ASHM’s Decision Making in Contraception: Consultation Essential resource to conduct patient-centred and evidence-based contraceptive consultations. Through the demonstration consultation, viewers will...
American Society for Microbiology, 1st September 2015 In recent years, evidence has been building that injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera or DMPA) is associated with an increased risk of HIV infection. Now a study published in the September 1st issue of mBio, an online open-access journal of the American Society for Microbiology, provides a biological...
Hi SASHA readers,
Some people have pointed out that the link in the previous post “Depo-Provera Linked to Increased HIV Risk in Africa” goes to a login page which locks them out. I found the article through google, and it turns out you can only access it in you go in that way, i.e. via google results. I was not aware of this when i posted it.
Cheers,
SASHA
Medscape, January 09, 2015
The injectable contraceptive depot medroxyprogesterone (Depo-Provera or DMPA) is associated with elevated risk for HIV infection among women in low-income or middle-income countries of sub-Saharan Africa, according to a study.
The mechanism behind a link between DMPA and HIV infection is not known.
Read more here